PrimeVigilance, an Ergomed company, was established in 2008 by the current Chairman of the Ergomed plc Board, Dr. Miroslav Reljanovic to provide specialised pharmacovigilance services to pharmaceutical and biotechnology companies.
WHO defines pharmacovigilance services as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Since its inception, PrimeVigilance has developed additional services, including medical information call centres, and has grown to become one of the global leaders in its field, providing services to over 140 client companies in more than 100 countries. PrimeVigilance continues to expand as it strives to become the leading global pharmacovigilance and medical information service provider, complementing Ergomed’s leading CRO capabilities. The company’s mission is a world with safer drugs.
PrimeVigilance Ltd – Part of Ergomed Group The Surrey Research Park, 1 Occam Court, Guildford, Surrey, GU2 7HJ Tel: +44 (0)1483 307920 • Fax: +44 (0)1483 307929 • email@example.com www.primevigilance.com